SNT
Click for more information
0.00% 4.3¢ syntara limited

Ann: Bronchitol Paediatric CF Trial Reports Postive Results, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. ramblehe
    1,403 Posts.
    lightbulb Created with Sketch. 21
    clock Created with Sketch.
    16/12/15
    08:40
    Post #: 16623104
    Pharmaceutical research company Pharmaxis (ASX: PXS) is pleased to announce positive results of its recently completed Phase II trial of Bronchitol® (mannitol) in children and adolescents with cystic fibrosis (CF). The trial, conducted across 39 global centres, met its primary endpoint and confirms that Bronchitol is efficacious in young patients, regardless of concomitant dornase alfa use.


    PXS Price at posting: 25.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The ASX can overlook its Telecomm smallcaps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS NRW Holdings inks $109M deal with BHP for works at Jimblebar
right-arrow Created with Sketch.
NEWS Maiden exploration and drilling preparations underway at high-grade Achilles project
right-arrow Created with Sketch.
NEWS High-grade lithium uncovered at Orrvik, Sweden with 11.55m at 1.45% Li2O including 3m at 3.11% Li2O from surface
right-arrow Created with Sketch.
NEWS Exploration drilling kicks off at Truncheon & Highway East, targeting copper-gold near historic mine
right-arrow Created with Sketch.
NEWS Full funding secured for Pular lithium project development: joint venture nears completion
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $59.04M
Open High Low Value Volume
4.3¢ 4.3¢ 4.2¢ $20.22K 474.7K

Buyers (Bids)

No. Vol. Price($)
1 25780 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 581744 4
View Market Depth
Last trade - 15.54pm 11/10/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.